Skip to main content
German

Clinical Evidence

The Most Robust Body of Clinical Evidence

No other company has committed so fully to establishing clinical evidence for the safety and efficacy of a spinal cord stimulation (SCS) system. HF10® therapy is backed by two prospective 24-month trials1,2 and a large body of real-world data.3

Long Term Durable Results

The landmark SENZA-RCT2 demonstrated long-term safety and improved efficacy for both back and leg pain with HF10 therapy.

View The Senza-rct
Back Pain
Leg Pain
Back Pain
Leg Pain
Long-Term Responder Rates

Reproducible Real-World Outcomes

In a real-world study, patients achieved a 74% responder rate, mirroring the excellent outcomes of the SENZA-RCT.

View The Publication

HF10 Therapy Provides Significant Reduction in Opioid Intake at Two Years1

Nearly 70% average reduction of morphine-equivalent dose1

Mean Morphine Equivalent Per Patient

1. Al-Kaisy A, Van Buyten J-P, Smet I, Palmisani S, Pang D, Smith T. Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study. Pain Med. 2014;15:347-354. 2. Kapural L, et al. Comparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: 24-month Results from a Multicenter, Randomized, Controlled Pivotal Trial. Neurosurgery. Published 09 2016 3. Stauss, T, et al. A multicenter real-world review of 10 kHz SCS outcomes for treatment of chronic trunk and/or limb pain. Annals of Clinical and Translational Neurology. Jan. 22, 2019. *Mean time from implant to last visit is nine months.